CM Life Sciences III (CMLT) Shareholders Approve EQRx Deal
by Marlena Haddad on 2021-12-17 at 6:23am

CM Life Sciences III (NASDAQ:CMLT) announced this morning that its shareholders approved its combination with biotech firm EQRx in a special meeting yesterday.

The 8-K did not disclose redemption figures but, CM III went into the vote with at least some risk having traded below $10 since August. Following close, the combined company is expected to trade on the Nasdaq under the symbol “EQRX”

CM Life Sciences III initially announced the $3.54 billion combination with EQRx on August 6. Cambridge, Massachusetts-based EQRx is developing a range of drug candidates both generated in-house and licensed from peers with an aim to reducing the overall cost of pharmaceutical rollouts.

All measures on the company’s ballot passed by large margins, but some received dissenting votes amounting to about 19% of participating shares. For full vote tallies, click here.


ADVISORS

  • J.P. Morgan Securities, LLC is acting as the lead financial advisor, with Goldman Sachs & Co. LLC also acting as a financial advisor.
  • PJT Partners LP is also acting as a financial advisor and Goodwin Procter LLP is serving as the legal advisor to EQRx.
  • Jefferies LLC and Cowen and Company, LLC are acting as joint capital markets advisors.
  • White & Case LLP is serving as legal advisor to CM Life Sciences III.
  • Jefferies LLC, Cowen and Company, LLC and J.P. Morgan Securities LLC are acting as joint placement agents.
CM Life Sciences III (CMLT) Shareholders Approve EQRx Deal
Recent Posts
by Kristi Marvin on 2025-06-28 at 10:02am

Terms Tracker for the Week Ending June 27, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. June continued its late-month rally with another five SPAC IPOs pricing this week, bringing the monthly total to 10 and the 2025 year-to-date count to...

by Nicholas Alan Clayton on 2025-06-27 at 11:20am

Blueport (NASDAQ:BPACU) has filed for a $69 million SPAC that would bring another first-time sponsor team to market. The new SPAC is offering investors a right to a 1/6 share in each unit and it will have 15 months to complete a business combination. It is underwritten by Alliance Global Partners and will not be...

by Nicholas Alan Clayton on 2025-06-27 at 8:25am

At the SPAC of Dawn The markets appear to poised to continue a rosy week with futures in the green in anticipation of PCE inflation readings. Space is one of the sectors feeling the most love recently and launch services firm Rocket Lab (NASDAQ:RKLB) is keeping up the momentum, scheduling two launches within 48 hours...

by Nicholas Alan Clayton on 2025-06-26 at 7:04pm

FIGX Acquisition Corp. (NASDAQ:FIGXU) announced the pricing of its $131 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “FIGXU”, Friday, June 27, 2025. The new SPAC aims to seek out a financial services target with a particular focus on wealth and asset managers with the potential to...

by Nicholas Alan Clayton on 2025-06-26 at 4:52pm

Yorkville Acquisition Corp. (NASDAQ:YORKU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “YORKU”, Friday, June 27, 2025. The new SPAC plans to combine with a target company in the telecom, media or technology sectors. Yorkville Acquisition Corp.’s management team is led...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved